Cetera Advisors LLC Novartis Ag Transaction History

Cetera Advisors LLC

$0
Q1 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$95.27 - $108.47 $1.09 Million - $1.24 Million	11,395 Added 82.69%	25,175 $2.44 Million
Q4 2023 Feb 13, 2024	BUY	$92.27 - $101.54 $23,159 - $25,486	251 Added 1.86%	13,780 $1.39 Million
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $38,934 - $43,208	411 Added 3.13%	13,529 $1.38 Million
Q2 2023 Aug 09, 2023	BUY	$92.52 - $104.91 $2,775 - $3,147	30 Added 0.23%	13,118 $1.32 Million
Q1 2023 May 15, 2023	BUY	$80.03 - $92.81 $107,720 - $124,922	1,346 Added 11.46%	13,088 $1.2 Million
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $208,064 - $254,800	2,754 Added 30.64%	11,742 $1.07 Million
Q3 2022 Nov 10, 2022	SELL	$74.61 - $87.26 $6,491 - $7,591	-87 Reduced 0.96%	8,988 $683,000
Q2 2022 Aug 11, 2022	BUY	$80.52 - $93.75 $136,239 - $158,625	1,692 Added 22.92%	9,075 $767,000
Q1 2022 May 12, 2022	BUY	$80.11 - $90.62 $36,209 - $40,960	452 Added 6.52%	7,383 $648,000
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $109,826 - $121,443	-1,378 Reduced 16.58%	6,931 $606,000
Q3 2021 Nov 16, 2021	BUY	$81.78 - $95.14 $26,742 - $31,110	327 Added 4.1%	8,309 $679,000
Q2 2021 Aug 13, 2021	SELL	$85.24 - $94.15 $4,347 - $4,801	-51 Reduced 0.63%	7,982 $728,000
Q1 2021 May 17, 2021	BUY	$83.5 - $98.47 $121,576 - $143,372	1,456 Added 22.14%	8,033 $687,000
Q4 2020 Feb 17, 2021	SELL	$78.07 - $94.43 $47,232 - $57,130	-605 Reduced 8.42%	6,577 $621,000
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $55,280 - $61,243	-673 Reduced 8.57%	7,182 $625,000
Q2 2020 Aug 13, 2020	BUY	$80.93 - $91.1 $160,241 - $180,378	1,980 Added 33.7%	7,855 $686,000
Q1 2020 May 08, 2020	SELL	$70.67 - $99.01 $11,660 - $16,336	-165 Reduced 2.73%	5,875 $484,000
Q4 2019 Feb 10, 2020	SELL	$84.35 - $95.37 $184,810 - $208,955	-2,191 Reduced 26.62%	6,040 $568,000
Q3 2019 Nov 06, 2019	BUY	$85.54 - $94.26 $37,979 - $41,851	444 Added 5.7%	8,231 $714,000
Q2 2019 Aug 12, 2019	SELL	$75.4 - $92.8 $13,496 - $16,611	-179 Reduced 2.25%	7,787 $707,000
Q1 2019 May 06, 2019	BUY	$75.32 - $86.15 $156,966 - $179,536	2,084 Added 35.43%	7,966 $764,000
Q4 2018 Feb 15, 2019	SELL	$73.66 - $82.02 $174,132 - $193,895	-2,364 Reduced 28.67%	5,882 $507,000
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $321,245 - $371,586	4,799 Added 139.22%	8,246 $712,000
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $99,701 - $112,680	-1,536 Reduced 30.82%	3,447 $258,000
Q1 2018 May 09, 2018	SELL	$70.39 - $84.15 $985 - $1,178	-14 Reduced 0.28%	4,983 $401,000
Q4 2017 Feb 08, 2018	SELL	$72.33 - $77.64 $86,796 - $93,168	-1,200 Reduced 19.36%	4,997 $421,000
Q3 2017 Nov 16, 2017	BUY	$74.14 - $77.27 $63,463 - $66,143	856 Added 16.03%	6,197 $534,000
Q2 2017 Aug 14, 2017	BUY	N/A	5,341	5,341 $448,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisors LLC with notifications on news.

Account